CIBC Asset Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,993
| Closed | -$208K | – | 1083 |
|
|
2023
Q2 | $208K | Hold |
8,993
| – | – | ﹤0.01% | 949 |
|
|
2023
Q1 | $209K | Buy |
+8,993
| New | +$209K | ﹤0.01% | 920 |
|
|
2021
Q4 | – | Sell |
-8,927
| Closed | -$288K | – | 1580 |
|
|
2021
Q3 | $288K | Buy |
8,927
+330
| +4% | +$10.6K | ﹤0.01% | 1045 |
|
|
2021
Q2 | $263K | Hold |
8,597
| – | – | ﹤0.01% | 1083 |
|
|
2021
Q1 | $262K | Buy |
+8,597
| New | +$262K | ﹤0.01% | 1034 |
|
|
2020
Q4 | – | Sell |
-10,190
| Closed | -$133K | – | 1260 |
|
|
2020
Q3 | $133K | Buy |
10,190
+72
| +0.7% | +$940 | ﹤0.01% | 1047 |
|
|
2020
Q2 | $115K | Hold |
10,118
| – | – | ﹤0.01% | 1028 |
|
|
2020
Q1 | $145K | Hold |
10,118
| – | – | ﹤0.01% | 909 |
|
|
2019
Q4 | $276K | Buy |
+10,118
| New | +$276K | ﹤0.01% | 905 |
|
|
2017
Q4 | – | Sell |
-8,559
| Closed | -$310K | – | 1086 |
|
|
2017
Q3 | $310K | Buy |
8,559
+108
| +1% | +$3.91K | ﹤0.01% | 796 |
|
|
2017
Q2 | $218K | Buy |
+8,451
| New | +$218K | ﹤0.01% | 891 |
|